Article
Diagnostic Utility of Chromosomal Microarray Analysis in a Turkish Pediatric Cohort: Insights from 1,022 Patients with Neurodevelopmental Disorders and Congenital Anomalies.
Cytogenetic and genome research - 1 Jan 2026
Sanri Aslihan, Mutlu Mehmet Burak, Sezer Ozlem
Abstract excerpt
BACKGROUND: Chromosomal microarray analysis (CMA) is a first-tier diagnostic test for children with unexplained developmental and/or congenital anomalies. This study aimed to evaluate the diagnostic contribution of CMA in a large, phenotypically diverse Turkish pediatric cohort. METHODS: CMA was performed in 1,022 children presenting with developmental delay, intellectual disability, autism spectrum disorder,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
